Ashfords advised Vamstar on the deal. Vamstar executed a $9.5 million Series A funding round, led by Korean investors Mirae Asset and Celltrion. Vamstar is a leading AI-based...
Vamstar’s $9.5 Million Series A Funding Round
BDx’s Joint Venture with PT Indosat Tbk PT Aplikanusa Lintasarta and SMT
King & Wood Mallesons advised Big Data Exchange (BDx) on the CSPA and joint venture agreement. SSEK Legal Consultants Big Data Exchange (BDx), a leading data...
TAL Dai-ichi Life Australia Pty Limited’s $900 Million Acquisition of Insurance Business from Westpac
King & Wood Mallesons advised Westpac on the sale of its life insurance business to TAL Dai-ichi Life Australia Pty Limited (TAL), and the exclusive 20...
Iksuda Therapeutics’ £29.6 Million Series A Financing Round
Ashfords advised life sciences company Iksuda Therapeutics on the deal. Bird & Bird advised Mirae Asset Capital, Celltrion and Premier Partners. Iksuda is the developer of...
Iksuda Therapeutics’ £29.6 Million Series A Financing Round
Ashfords advised life sciences company Iksuda Therapeutics on the deal. Bird & Bird advised Mirae Asset Capital, Celltrion and Premier Partners. Iksuda is the developer of...
LGIAsuper’s Acquisition of Suncorp Portfolio Services Limited
King & Wood Malleson advised Suncorp Group Limited on the strategic sale of its Australian Wealth Business, Suncorp Portfolio Services Limited, to LGIAsuper, following a competitive...